Dangers involved in rapid opioid detoxification while using opioid antagonists: Dehydration and renal failure

Addiction

Volumn 97, Issue 8, 2002, Pages 1071-1073

  Roozen, H G ^a   De Kan, R ^a   Van Den Brink, W ^a   Kerkhof, B J F M ^a   Geerlings, P J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DEXAMETHASONE; LORAZEPAM; MIDAZOLAM; NALTREXONE; ONDANSETRON; OPIATE ANTAGONIST;

ADULT; ARTICLE; CASE REPORT; DEHYDRATION; DETERIORATION; DETOXIFICATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

ADULT; DEHYDRATION; HUMANS; KIDNEY FAILURE, ACUTE; MALE; METHADONE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS;

EID: 0036348516     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2002.00122.x     Document Type: Article

References (8)

1. Practice guidelines for the treatment of patients with substance use disorders: Alcohol, cocaine, opioids
2. A pilot study of naltrexone accelerated detoxification in opioid dependence
3. Addict died after rapid opiate detoxification
4. Opioid antagonists under sedation or anaesthesia for opioid withdrawal
5. Rapid and ultrarapid opioid detoxification techniques
6. Opiate detoxification under anesthesia: No apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure
7. High risk of ultrashort noninvasive opiate detoxification
8. Naloxone inhibits renal hemodynamic effect of head-out immersions in humans